Mixed results for delistings in Singapore

Templeton questions MBKÆs offer to buy out minority shareholders in AsiaPharm, while TecityÆs plan to delist Straits Trading gets a fillip as the competing bidder withdraws.

Delisting hopefuls in Singapore have achieved mixed results this week with MBK hitting a hurdle in its $252 million plan to delist AsiaPharm, and Tecity moving a step forward in its $1.5 billion bid for Straits Trading.

The bid by private equity firm MBK Partners for AsiaPharm was in focus yesterday when Templeton Asset Management president Mark Mobius said the fund was ônot convinced by the offerö. Mobius says the offer price ôseverely undervalues AsiaPharm and is...

To continue reading, please login or register for free

Click for more on: asiapharm | mbk | templeton | mark mobius | straits trading | tecity | ocbc

Print Edition

FinanceAsia Print Edition


  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...